Pathology of PF-ILD associated with RB-ILD is a dubious disease in the area of infectious respiratory digestive and endocrine disorders, clinical manifestations are complex and often involve multiple systemic strain. Early identification and standardized clinical treatment are essential for improving prognosis. Diagnosis of this disease requires a combination of clinical manifestations, imaging checks, laboratory tests and pathological activation.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutically oriented, immune-regulatory therapies and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored during treatment and timely adjusted according to changes in disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PF-ILD and RB-ILD pathologies. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1. Remote pre-diagnosis: pre-examination of medical records, precise diagnostic directions and medical advice by the team of experts; 2.
Interviews in China: arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3. Full-service: one-stop services: medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishment of a chronic disease management file, continuous monitoring of changes in disease and treatment effects.
Support for remote pre-diagnosis, visiting interviews, full translation and escort.